Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan
Riverside Resources and Sierra Madre Developments have obtained assay results of a comprehensive soil sampling program that was specifically designed to test the possible west expansions of the oxide gold mineralization, which was identified during the phase I drill program conducted at the El Capitan target in Penoles project.
Mineralized gold of economic grade was discovered in the El Capitan drill program over a strike of around 700 m and the mineralized zone seems to be exposed for an extension along strike towards the area’s west and northwest part.
An oxide gold prospect that is partly outlined, two former silver mines and several targets of previous phase are present in the Penoles project. Those early phase targets located in a land package, enclose over half of the former Penoles Mining district.
A near-surface overburden masks the zone mineralization at the El Capitan together with the possible extension. The company has decided to complete a comprehensive soil sampling before performing further drill testing. It gathered a total of 980 samples at the intervals of 12.5 m along 25 m of spaced profile lines for along the strike for more than 350 m of the zone mineralization. Nevada-based Inspectorate Laboratories examined the soil samples with the help of standard fire assay methods and strong anomalous values of gold are found within west-northwest striking anomaly of thickness from 150 to 250 m. This anomaly expands from the DDH 11-05 across the complete survey grid and is exposed towards the western part. Many soil samples from the southwest part of DDH 11-05 yielded strong anomalous values of gold. The company has planned to start further drill testing at El Capitan target. The results are pending.
Written by
Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.
Please use one of the following formats to cite this article in your essay, paper or report:
APA
Scanlon, Joel. (2019, February 18). Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan. AZoMining. Retrieved on February 02, 2026 from https://www.azomining.com/News.aspx?newsID=6191.
MLA
Scanlon, Joel. "Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan". AZoMining. 02 February 2026. <https://www.azomining.com/News.aspx?newsID=6191>.
Chicago
Scanlon, Joel. "Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan". AZoMining. https://www.azomining.com/News.aspx?newsID=6191. (accessed February 02, 2026).
Harvard
Scanlon, Joel. 2019. Riverside Resources, Sierra Madre Developments Receive Soil Sampling Assays from El Capitan. AZoMining, viewed 02 February 2026, https://www.azomining.com/News.aspx?newsID=6191.
We're committed to providing free access to quality science. By registering and providing insight into
your preferences you're joining a community of over 1m science interested individuals and help us to
provide you with insightful content whilst keeping our service free.
or
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.